Aurobindo Pharma Limited Aurobindo Pharma Limited

Aurobindo Pharma Limited

AUROPHARMA

株式のランク #2074
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
株価
$17.34
時価総額
$9.98B
変化(1日)
-3.08%
変化(1年)
38.71%
国
IN
取引 Aurobindo Pharma Limited (AUROPHARMA)

カテゴリー

Healthcare
Aurobindo Pharma Limited(AUROPHARMA)の株式分割履歴
Aurobindo Pharma Limited株(シンボル:AUROPHARMA)は合計で5回の株式分割を実施しました。
最新の株式分割はJul 20, 2015に行われました。
Oct 26, 1998より前に購入されたAUROPHARMA株は、現在80AUROPHARMA株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
2015-07-20 2:1 x2 x80
2011-02-10 5:1 x5 x40
2003-10-23 2:1 x2 x8
2000-03-20 2:1 x2 x4
1998-10-26 2:1 x2 x2
類似企業または競合他社の株式分割